| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,176 | 1,182 | 09:32 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.01. | Rejlers awarded contract for Oriola's new high-tech distribution centre in Järvenpää | 1 | Cision News | ||
| 15.01. | ORIOLA OYJ: Proposals of the Shareholders' Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2026 Annual General Meeting | 1 | Cision News | ||
| 07.01. | ORIOLA OYJ: Oriola initiates review of long-term plan, financial targets and capital allocation priorities - Capital Markets Day scheduled | 4 | Cision News | ||
| 07.01. | ORIOLA OYJ: Inside information: Oriola accelerates growth and modernises Finnish operations with a highly automated, state-of-the-art distribution centre in Järvenpää | 1 | Cision News | ||
| 07.01. | Oriola Corporation: Inside information: Oriola accelerates growth and modernises Finnish operations with a highly automated, state-of-the-art distribution centre in Järvenpää | 110 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 7 January 2026 at 12:35 p.m. EET
Inside information: Oriola accelerates growth and modernises Finnish operations with a highly automated, state-of-the-art... ► Artikel lesen | |
| 07.01. | Oriola Corporation: Oriola initiates review of long-term plan, financial targets and capital allocation priorities - Capital Markets Day scheduled | 88 | GlobeNewswire (Europe) | Oriola Corporation Investor news 7 January 2026 at 12:30 p.m. EET
Oriola initiates review of long-term plan, financial targets and capital allocation priorities - Capital Markets Day scheduled
Following... ► Artikel lesen | |
| 19.12.25 | ORIOLA OYJ: Kronans Apotek to record an impairment with an impact of approximately EUR 16 million to Oriola's net result | 1 | Cision News | ||
| 15.12.25 | ORIOLA OYJ: Change negotiations in connection with Oriola's plan for a new distribution centre in Finland have been concluded | 1 | Cision News | ||
| ORIOLA Aktie jetzt für 0€ handeln | |||||
| 30.10.25 | ORIOLA OYJ: Oriola Corporation's Interim Report January-September 2025 | 2 | Cision News | ||
| 30.10.25 | Oriola Corporation: Oriola Corporation's Interim Report January-September 2025 | 140 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 30 October 2025 at 8.30 a.m. EET
Oriola Corporation's Interim Report January-September 2025
Sales margin growth and improved adjusted EBITDA
July-September... ► Artikel lesen | |
| 09.10.25 | ORIOLA OYJ: Pansuola launches two new spices - less sodium, more flavour | 1 | Cision News | ||
| 02.10.25 | ORIOLA OYJ: Oriola appoints Maria Lundell as Chief People Officer | 1 | Cision News | ||
| 02.10.25 | Oriola Corporation: Oriola appoints Maria Lundell as Chief People Officer | 159 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 2 October 2025 at 2:00 p.m. EEST
Oriola appoints Maria Lundell as Chief People Officer
Maria Lundell, MA has been appointed Oriola Corporation's Chief People... ► Artikel lesen | |
| 01.09.25 | Unbounce CEO Steve Oriola Shares 2025 SaaS Growth Strategy on the DesignRush Podcast | 399 | Newsfile | Miami, Florida--(Newsfile Corp. - September 1, 2025) - On episode 104 of the DesignRush Podcast, Steve Oriola, CEO of Unbounce, reveals key strategies for scaling SaaS in 2025, with a focus on timing... ► Artikel lesen | |
| 20.08.25 | ORIOLA OYJ: Oriola's ambitious science-based climate targets approved by the SBTi | 1 | Cision News | ||
| 18.07.25 | Oriola Corporation: Oriola Corporation's Half-Year Report January-June 2025 | 223 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 18 July 2025 at 8.30 a.m. EEST
Oriola Corporation's Half-Year Report January-June 2025
Strong partnerships drive Distribution growth and profitability
April-June... ► Artikel lesen | |
| 18.06.25 | Oriola Corporation: Oriola signed EUR 70 million revolving credit facility | 164 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 18 June 2025 at 1:00 p.m. EEST
Oriola signed EUR 70 million revolving credit facility
Oriola Corporation has entered into a EUR 70 million revolving credit... ► Artikel lesen | |
| 29.04.25 | Oriola Corporation: Oriola Corporation's Interim Report January-March 2025 | 276 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 29 April 2025 at 8.30 a.m. EEST
Oriola Corporation's Interim Report January-March 2025
Steady growth and progress towards long-term goals - outlook refined
January-March... ► Artikel lesen | |
| 02.04.25 | Oriola Corporation: Resolutions of the Annual General Meeting of Oriola Corporation - Combination of share classes and thereto related directed issuance of shares without payment approved | 247 | GlobeNewswire (Europe) | Oriola Corporation's Stock Exchange Release 2 April 2025 at 6:00 p.m.
Resolutions of the Annual General Meeting of Oriola Corporation - Combination of share classes and thereto related directed issuance... ► Artikel lesen | |
| 04.03.25 | Oriola Corporation: Oriola Corporation's Financial Statements Release 1 January-31 December 2024 | 219 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 4 March 2025 at 8.30 a.m. EET
Oriola Corporation's Financial Statements Release 1 January-31 December 2024
Strategy implementation enhances financial performance
October-December... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,490 | +0,59 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 37,40 Euro auf "Underweight" belassen. Analyst David Adlington nahm am Donnerstagabend in seinem... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,320 | +1,81 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 53 Euro auf "Neutral" belassen. Europas Medizintechnik-Branche stehe vor einem... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,540 | 0,00 % | Gerüchte & Nervosität bei Eckert&Ziegler: Was steckt dahinter? | ||
| GERRESHEIMER | 26,820 | +1,28 % | Gerresheimer-Aktie // Boden scheint gefunden | Eine beeindruckende Talfahrt erlebte die Gerresheimer-Aktie in den vergangenen Jahren. Nachdem im Herbst 2023 bei 122,90 Euro noch ein Rekordhoch erreicht worden war, ging es bis auf ein Zwischentief... ► Artikel lesen | |
| TELADOC HEALTH | 4,873 | +1,31 % | Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? | ||
| STRATEC | 22,550 | 0,00 % | BERENBERG stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Stratec auf "Buy" mit einem Kursziel von 46 Euro belassen. 2025 sei ein weiteres durchwachsenes Jahr für den Medizintechnik-/Life-Sciences-Sektor... ► Artikel lesen | |
| ROKU | 84,08 | -0,40 % | This genius new Roku feature helps you find everything you need much faster - here's how | ||
| M1 KLINIKEN | 17,180 | 0,00 % | M1 Kliniken: Zimmnau in den Vorstand berufen | M1 Kliniken erweitert den Vorstand: Einer Meldung des Berliner Unternehmens vom Donnerstag zufolge hat man "Katharina Zimmnau mit Wirkung zum 10.12.2025 in den Vorstand der M1 Kliniken AG berufen".... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,690 | -2,18 % | Geratherm Medical AG: Segmentwechsel | Geratherm Medical AG,
Geratal
ISIN: DE0005495626
bisheriges Segment: Freiverkehr - Scale
künftiges Segment: Freiverkehr - Basic Board
Änderung ab 28. April 2026
Frankfurt am Main, den 28.... ► Artikel lesen | |
| DEXCOM | 61,09 | -0,54 % | Could 2026 Be Dexcom's 'Get Right' Year? New CEO Jake Leach Says Yes. | ||
| RESMED | 214,90 | -0,42 % | Resmed's Q2 Earnings on Deck: What's in Store for the Stock? | ||
| CARDINAL HEALTH | 175,50 | -0,34 % | Cardinal Health stock price target raised to $233 from $225 at TD Cowen | ||
| BAXTER | 16,312 | -0,66 % | Reasons to Retain Baxter International Stock in Your Portfolio Now | ||
| MEDICLIN | 4,000 | 0,00 % | EQS-News: MEDICLIN AG: Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025 | EQS-News: MEDICLIN AG
/ Schlagwort(e): Personalie
Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025
16.12.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,524 | +1,75 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report |